Skip to main content
PLOS One logoLink to PLOS One
. 2026 Apr 24;21(4):e0345413. doi: 10.1371/journal.pone.0345413

Bayesian probabilistic projections of proportions with limited data: An application to subnational contraceptive method supply shares

Hannah Comiskey 1,*, Niamh Cahill 2, Leontine Alkema 3, David T Frazier 1, Worapree Maneesoonthorn 1
Editor: Juan Pablo Gutierrez4
PMCID: PMC13108902  PMID: 42030401

Abstract

Engaging the private sector in contraceptive method supply is critical for creating equitable, sustainable, and accessible healthcare systems. To achieve this, it is essential to understand where women obtain their modern contraceptives. While national-level estimates provide valuable insights into overall trends in contraceptive supply, they often obscure variation within and across subnational regions. Addressing localised needs has become increasingly important as countries adopt decentralised models for family planning services. Decentralization has also underscored the need for reliable subnational estimates of key family planning indicators. The absence of regularly collected subnational data has hindered effective monitoring and decision-making. To bridge this gap, we propose a novel approach that leverages latent attributes in Demographic and Health Survey (DHS) data to produce Bayesian probabilistic projections of contraceptive method supply shares (the proportions of modern contraceptive methods supplied by public and private sectors) with limited data. Our modelling framework is built on Bayesian hierarchical models. Using penalized splines to track public and private supply shares over time, we leverage the spatial nature of the data and incorporate a correlation structure between recent supply share observations at national and subnational levels. This framework contributes to the domain of subnational estimation of proportions in data-sparse settings, outperforming comparable and previous approaches. As decentralization continues to reshape family planning services, producing reliable subnational estimates of key indicators is increasingly vital for researchers and policymakers.

Introduction

FP2030 is a global partnership committed to empowering women and girls through investments in rights-based family planning [1]. This approach emphasizes accessibility and availability of contraceptives [2]. Traditionally, the public sector has led family planning efforts [3], but declining donor funding has spurred interest in private sector engagement [46]. Leveraging private sector contributions enhances equitable, accessible, and sustainable reproductive healthcare [7,8]. Recent initiatives, such as WHO’s 2024 online training for pharmacists, aim to expand contraceptive access in low- and middle-income countries [9]. Pharmacies play a crucial role, particularly in providing short-term methods like oral contraceptives and condoms [10]. Unmarried women and teenagers disproportionately rely on the private sector due to privacy concerns [11]. Therefore, understanding contraceptive access patterns is essential for equity [8,11]. National estimates of family planning indicators aid global reporting but overlook local trends and fail to assess if target levels for indicators are being ubiquitously attained across the nation. Furthermore, a decentralised approach to family planning management improves sector performance [12,13]. Subnational estimates are widely used in demography for tracking contraceptive prevalence, unmet need, and under-5 mortality [1416], yet gaps remain in monitoring contraceptive supply sources.

Small area estimation (SAE) involves estimating characteristics of sub-populations, where there may be few or no samples available, by ‘borrowing strength' from related populations to improve accuracy [17]. Using SAE approaches to model demographic and health outcomes is a well-established practice. In 1979, the foundational Fay-Herriot modelling approach described a two-stage hierarchical area-level model that allowed for the weighted estimates of area-level characteristics [18]. Building on this, in 1991 Basag, York, and Mollie (BYM) described an approach that uses both spatially structured variation and independent unstructured variation to capture underlying disease prevalence [19]. Since these models, the area of SAE has exploded with progress in many different directions including generalised linear mixed models, Bayesian hierarchical models, and conditional auto-regressive (CAR) models [2024].

Previous works modelled the distribution of contraceptive method supply shares at the national level using a Bayesian hierarchical penalized spline model, and then explored the application of this modelling framework to subnational data [25,26]. While performing relatively well across a range of validation measures, this paper revisits the modelling framework of Comiskey et al. (2024) with the aim of improving its suitability for estimating and projecting proportions, while addressing the complex structure of subnational DHS administrative data. In this article, we describe a Bayesian hierarchical penalized spline model that produces annual, subnational, and method-specific estimates of the proportion of modern contraceptives coming from the public sector. In the context of SAE, Bayesian hierarchical models allow for the pooling of information across larger populations to inform smaller sub-population estimates, where data is sparser. As a result, these models provide a powerful framework for estimating subnational method supply shares. The Comiskey et al. (2024) approach also estimates and incorporates cross-method correlations to inform the rates of change in spline coefficients. However, due to the heterogeneity of subnational data, capturing cross-method correlations within the rates of change between spline coefficients becomes difficult. Instead, we present an approach that captures the cross-method correlations for the most recently observed survey levels of public sector supply shares. Finally, Comiskey et al. (2024) estimate a multivariate compositional outcome across three-way breakdown of the contraceptive supply market. Due to small sample sizes at the subnational level, we instead focus on a simplified public–private breakdown of the outcome.

Overall, we have modified the national-level modelling approach of Comiskey et al. (2024) to subnational regions where the sampling density is lower (i.e., fewer women sampled per estimate) and consequently the uncertainty associated with the survey observations is higher than what is observed as the national level. Like Comiskey et al. (2024), the updated approach relies on Bayesian hierarchical estimation for key parameters, but introduces an updated prior structure within the proposed modelling framework. The proposed framework now provides estimates of the latent cross-method correlations that exist between the most recently observed levels of contraceptive method supply shares. Finally, the flexibility of this updated modelling approach captures the nature of an otherwise complex time- and spatially-varying dataset. At the time of writing, these subnational estimates with associated uncertainty represent a significant advancement in monitoring contraceptive supply shares. While our focus is the specific supply-share monitoring scenario, we note that this more parsimonious modeling approach is highly generalisable and can be applied to a wide range of datasets beyond the current context. By structuring the model to capture both hierarchical dependencies and flexible distributional assumptions, it can accommodate different levels of aggregation, varying sample sizes, and diverse outcome types; e.g., the proportion of women who received antenatal care from a skilled provider or proportion of children vaccinated between 12–23 months [2730].

The outline of this paper is as follows. We begin with the definitions used throughout this paper and the data utilised in this approach. In the Methods section we describe the hierarchical penalised spline model. In Results, we consider the output of this model, which we then compare with various approaches listed in the Supplementary Materials, via an extensive model comparison study. We conclude the paper with a discussion. The Supplementary Materials contain more technical details and additional supporting information.

Definitions and data sources

Definitions

Modern contraceptive methods are defined as “a product or medical procedure that interferes with reproduction from acts of sexual intercourse” [31]. During this investigation, we consider five main modern methods of contraception. These are female sterilization, oral contraceptive pills (OC pills), implants (including Implanon, Jadelle and Sino-implant), intra-uterine devices (IUD, including Copper- T 380-A IUD and LNGIUS), and injectables (including Depo Provera (DMPA), Noristerat (NET-En), Lunelle, Sayana Press and other injectables). Contraceptive method supply shares are defined as “the percent distribution of the types of service-delivery points cited by users as the source of their current contraceptive method (if more than one source, then the most recent one)” [32]. This paper considers a public/private sector breakdown for each of the five contraceptive methods listed. Contraceptives supplied by government-funded health facilities and home/community deliveries are considered to be supplied by the public sector, while supplies that come from sources outside the public sector, including enterprises ran for-profit or non-profit, can be defined as coming from the private sector.

Data sources

Following the data curation approach described in Comiskey et al., we use a database of administration-1 level Demographic and Health Survey (DHS) observations for public and private sector modern contraceptive method supply shares with their associated standard errors [25]. This database was created on 01/09/2024 using the Integrated Public Use Microdata Series (IPUMS)-DHS data [33]. The authors did not have access to information that could identify individual participants during or after data collection. The variables contained within the IPUMS-DHS database are consistent over time and space, making them suitable for temporal and spatial analysis. The countries included in this study are selected from those participating in the FP2030 initiative with IPUMS-DHS data available after 2012 and were also previously considered in Comiskey et al. 2024. There are 23 countries containing 160 subnational regions, included in this study. The administration level used was the integrated geographic units calculated by IPUMS. Using the integrated geographic units ensured that the data had consistent boundaries across all years. To avoid issues with exact zeros or ones, on the logit scale, the data was condensed using the ‘lemon-squeezer’ method [34]. This simple transformation slightly shrinks all data points away from 0 and 1 while maintaining their relative ordering and approximate scale. To address issues with small sample size, we filtered the database to only include observations where at least one sector (public or private) has a sample size of at least 10 women. This removes sets of observations with large uncertainty. Sampling errors were calculated while accounting for the sampling design using a Taylor series linearisation method to approximate the standard error of the calculated proportions [35,36]. A complete description of this imputation process is described in the Supplementary Materials.

Table 1 gives a summary of each country included in the dataset. In this dataset, Burkina Faso has the oldest ‘latest’ survey, collected in 2010. In contrast, Madagascar has the newest ‘latest’ survey collected in 2021. Recorded in this dataset, 56% of countries collected their latest surveys between 2015 and 2018, while a further 28% of countries collected their latest survey in 2014 or before. Malawi, Guinea and Cameroon are divided into 3 subnational areas, making them the countries with the least number of subnational regions. The amount of survey data available also varies per country. Senegal has the largest number of surveys in the dataset with 9 surveys collected between 1990 and 2021, while Myanmar has only one survey present in the dataset.

Table 1. Summary information regarding the countries considered for subnational modelling. The name, number of subnational administration level 1 (admin-1) regions, the year of the first survey collected, the year of the most recently collected DHS survey, and the total number of DHS surveys are given for each country in the dataset.

Country Total subnational regions Earliest survey Latest survey Total surveys
Benin 6 2001 2017 4
Burkina Faso 14 1993 2010 4
Cameroon 3 1991 2018 4
Cote d’Ivoire 15 1994 2011 3
Ethiopia 10 2000 2019 5
Ghana 8 1993 2014 5
Guinea 3 1999 2018 4
Kenya 7 1993 2014 5
Liberia 5 2007 2019 4
Madagascar 6 1992 2021 5
Malawi 3 1992 2016 5
Mali 4 1995 2018 5
Mozambique 11 1997 2011 3
Myanmar 15 2015 2015 1
Nepal 5 1996 2016 5
Niger 6 1992 2012 4
Nigeria 7 1990 2018 6
Pakistan 6 1991 2017 4
Rwanda 5 1992 2019 7
Senegal 4 1992 2017 9
Tanzania 6 1991 2015 6
Uganda 4 1995 2016 4
Zimbabwe 10 1994 2015 5

Methods

Modelling approach

The outcome of interest is the components of a compositional vector,

ϕp,t,m=(ϕp,t,m,1,ϕp,t,m,2)  (1)

where ϕp,t,m,s  is the proportion supplied by the public (s = 1) or the private (s = 2) sector of modern contraceptive method m, at time t, in subnational administration region p and s=12ϕp,t,m,s=1 .

The documentation of the modelling assumptions is described using the standarised Temporal Models for Multiple Populations (TMMPs) framework [37]. First, we describe the process model which captures the latent dynamics of the outcome of interest. Secondly, we discuss the data model which links the observed data to the process model. In the process model, we model the logit-transformed proportion of the public sector supply share using a Bayesian hierarchical penalised spline model. The logit-transformed data is linked to the process in the data model via a Normal distribution.

Assuming a hierarchical estimation approach accounts for the spatial structure of the data, enabling subnational-level intercepts to benefit from information sharing within each country. Extending this assumption to a multivariate framework across methods allows the model estimates to further leverage latent cross-method correlations embedded in the covariance structure. A key advantage of this approach is the collective information sharing that occurs both across methods and within countries, spanning subnational administrative regions. This mitigates the effects of data sparsity observed in certain subnational regions and countries. The use of a random walk model of order 1 to estimate the coefficients of the penalised splines allows us to flexibly model non-linear trends, while the penalty term controls the degree of smoothness and prevents overfitting. Moreover, the approach builds on previous work that forecasts a steady state beyond the most recent survey observation [25,38].

The process model.

The logit-transformed public sector proportion, logit(ϕp,t,m,1 ), is modelled via a hierarchical structure depicted in Fig 1. We construct the spline using,

Fig 1. Flow diagram of the subnational supply share model.

Fig 1

A flow diagram illustrating the relationships among the parameters contributing to the estimation of subnational supply shares. From left to right, circular nodes represent variance parameters that inform the second-level model components. Intercepts and rates of change are combined to generate spline coefficients (shown as rounded rectangles). These spline coefficients are then combined with subnational area–specific basis functions to produce the estimated proportions (shown as hexagons). The estimated proportions are linked to their associated standard errors, calculated from DHS survey data and transformed to the logit scale using the Delta method. Together, these quantities connect to the observed data (shown as clipped rectangles).

logit(ϕp,t,m,1)=ψp,t,m=k=1Kβp,m,kBp,k(t)  (2)

where, ψp,t,m  is the latent variable capturing the logit-transformed public sector proportion. Bp,k(t) is the kth basis function evaluated at time t, in subnational administration region p. K is the total number of knots chosen for the set of basis functions. βp,m,k  is the kth spline coefficient for method m, in subnational administration region p. Within basis functions, knots are the points where the piece-wise polynomials join together over the input variable (e.g., x-axis). Following the approach outlined in Comiskey et al. (2024), we align a knot with the year of the most recently observed survey in subnational administration region p. This results in each subnational administration region p having a unique set of basis functions.

Aligning the knots of the basis function with the most recently observed survey year serves two purposes. Firstly, it allows steady state projections beyond the most recent survey year and secondly, it allows for a random walk model of order 1 estimation approach to the vector of K spline coefficients, βp,m . Let k* be the knot that aligns with the year of the most recently observed survey, then

βp,m,k={αp,mk=k*,βp,m,k+1δp,m,kk<k*,βp,m,k1+δp,m,k1k>k*.  (3)

where,

δp,m=(βp,m,2βp,m,1,βp,m,3βp,m,2,,βp,m,Kβp,m,K1).  (4)

We assume that the value of the spline coefficient at the point k* is αp,m . Moving backwards from k* to k = 1, we subtract the corresponding rates of change δp,m,k . Similarly, moving from k* towards k = K, we add the corresponding rates of change δp,m,k1 . We set a sum-to-zero constraint on the spline coefficients to ensure identifiability of the parameter estimates. The spline coefficient αp,m  acts as a proxy intercept in the modelling approach, as a change in αp,m  systemically shifts the set of public sector share projections. We specify a hierarchical prior using a multivariate Normal distribution, which is designed to capture both geographic and cross-method trends in the data. In this framework, subnational and method-specific trends are informed by country-level averages so that information is shared across regions and methods, which is known to improve inference in data-sparse settings, inducing a form of spatial dependence. We assume,

θmall~N(0,100),  (5)
θc,1:Mθmall,Σθ~MVN(θ1:Mall,Σθ),  (6)
αp,1:Mθc,1:M,Σα~MVN(θc,1:M,Σα),  (7)

where M is the total number of contraceptive methods considered. For country c and set of M methods, we assume that the intercepts θc,1:M  are centered on a cross-country method-specific mean θmall  with an associated variance-covariance matrix Σθ . θc,1:M  capture the most recently observed publicly supplied proportions at the national level and on the logit scale. Σθ  is MxM matrix which is constant across all countries. Similarly, the M intercepts of subnational administration region p, αp,1:M , are centered on a set of country-specific means, θc,1:M , with an associated cross-method variance-covariance matrix Σα  that is constant across all subnational administration regions. Finally, the variance-covariance matrices assume vague inverse-Wishart priors, centered on an identity matrix of size MxM with M + 1 degrees of freedom. The use of this prior assumes that the marginal distributions of the correlations between methods follow a uniform distribution. It is also conjugate prior to the multivariate Normal distribution, making it a suitable choice in our hierarchical estimation process [39].

Σθ~IW(IM,M+1),  (8)
Σα~IW(IM,M+1).  (9)

The rates of change between spline coefficients, δp,m,k , are modelled assuming a Normal prior with cross-method variance. We penalise the spline coefficients to remain steady over time, by assuming the expected rate of change to be 0. This acts as a penalty for the B-splines. A vague truncated-Normal prior was used to capture this variation.

δp,m,kσδ~N(0,σδ)  (10)
σδ~N(0,22)+.  (11)

The data model.

We link the latent variable ψp,t,m  to the logit-transformed observed public sector supply share, logit(yp,t,m), by assuming a Normal distribution likelihood such that,

logit(yp,t,m)ψp,t,m~N(ψp,t,m,SEp,t,m2).  (12)

Where SEp,t,m is associated standard error calculated using the DHS survey microdata and transformed onto the logit scale using the Delta method [40].

Computation

We used R and JAGS (Just Another Gibbs Sampler) to fit the model. JAGS uses Markov Chain Monte Carlo (MCMC) algorithm and Gibbs Sampling to produce model estimates for Bayesian Hierarchical models [41]. To evaluate the JAGS output we used ‘rjags’, an R package that offers cross-platform support from JAGS to the R interface [42]. The number of iterations used was 80,000. The burn-in period was set to 10,000. The samples were thinned to every 35th sample. Consequently, the posterior distribution is made up of 2000 samples. To assess convergence, we considered the R-hat and effective sample size (ESS) values of the model parameters using the plot function of rjags, as well as the trace plots and autocorrelation plots of individual parameters [43]. The results were a set of trajectories for the proportion of contraceptive m supplied by the public and private sectors over time for each subnational region included in the study. The mean of these results was taken to be the model’s point estimate. The 95% credible intervals were calculated using the 2.5th and 97.5th percentiles from the posterior distribution for each estimate.

Results

National and subnational correlations

Fig 2 shows the heat map of the estimated latent correlations between the five contraceptive methods considered in this study informing αp,m , the proxy-intercept, at the national (A) and subnational (B) levels across all subnational provinces. At the national level (Fig 2A), the estimated correlations are showing strong positive relationships between the long-term and permanent methods (LAPM). For OC pills, a short-term method, the estimated correlations with the other methods are weakly positive. This trend is in keeping with previous studies that found OC pills are a popular choice for women accessing contraceptive through the private sector [8,10,11]. In contrast, contraceptive methods that require a medical professional for administration are more likely to be accessed through the public sector. These correlations would imply that as the most recently observed public sector supply share of a given LAPM increases, the other LAPMs also tend to increase. For the subnational level correlations (Fig 2B), the estimated correlations between female sterilization and the other methods are the weakest with moderately-strong positive correlations (0.60–0.63). The remaining cross-method correlations are strong between 0.70 (OC pills and implants) and 0.80 (OC pills and IUDs). The estimated cross-method correlations at the subnational level are more homogenous than those observed at the national level. This may be due in part to the noisier signal observed at the subnational level.

Fig 2. Estimated (A) national- and (B) subnational-level cross-method correlations informing αp,m , the proxy-intercept.

Fig 2

The estimated mean correlations captured by the Wishart prior for the intercept term of the proposed model. The intercept is informed by the most recently observed public supply shares of each method across all (A) countries and (B) subnational administration regions. Each of the five methods is listed along the x- and y-axes, with the estimated mean correlation is given in each square, with the associated 95% credible interval underneath in brackets. The strength of the correlation is emphasized by the depth of the shade. Lighter infer correlations closer to 0, while darker colours infer stronger correlations.

Country case studies

While we produced model estimates based on model fit to the subnational provinces of 24 countries, we have chosen two case-study countries Nigeria and Rwanda to showcase the strength of our modelling approach. Both countries have varying amounts of data across the five contraceptive methods and have experienced changes in the modern contraceptive supply share trends over time.

Nigeria.

Fig 3 shows the estimated proportion of contraceptives supplied by the public and private sectors with uncertainty from 1990 to 2030 across the six geopolitical zones. The boundaries of these zones have been consistent for the duration of the observation period. Historically, only the North Central region of Nigeria has collected data on the supply of female sterilization. As such, the remaining regions are estimated via the hierarchical estimation process on the intercept. The estimated method supply share in the remaining regions is given by the most recently supplied share in the North Central region. With no data to inform any deviation from this observed level, coupled with the splines being penalised to project steadily into the future, we see flat trends occurring for these regions. In the North Central region, the model indicates an increasing trend between 2015 and 2020, approximately. In contrast to the data sparsity seen in female sterilization, injectables have between three and five survey observations per region. The flexibility of the splines is demonstrated here as the model is able to capture the complex nature of the data in each region. Historically, OC pills tends mostly to be provided by the private sector across all subnational regions. However, the model estimates indicate that this private sector supply share has been steadily declining over time. This is in contrast to the supply trends observed in other methods, where the public sector is the main supplier across all regions, and has remained relatively constant over time. Some smoothing is taking place as the data model is informed by the observed standard errors of the survey data. For this reason, observations with large associated standard errors are not as closely adhered to, when compared to observations with smaller uncertainty. This is clearly seen in North-Central OC pills where the model estimates smooth through the survey observation at 2003. When we consider the private sector supply shares spatially and over time, we can see geographical trends in the supply of certain methods (Fig 4). For instance with IUDs (Fig 4: IUDs), there appears to be a north-south split across Nigeria in the private sector supply over time. The northern half (North East and North West subnational regions) tend towards very low proportions of IUDs provided by the private sector while the southern half of the country (North Central, South West, South South, South East) sees higher proportions of IUDs supplied by the private sector. This trend is replicated in OC pills (Fig 4: OC Pills) where again, the northern half of the country tends to supply a lower proportion of OC pills via the private sector when compared to the southern half.

Fig 3. Estimated subnational contraceptive supply shares in Nigeria with uncertainty.

Fig 3

The projections for the proportion of modern contraceptives supplied by each sector for three of the five contraceptive methods, in the six geopolitical zones of Nigeria. The median estimates are shown by the continuous line while the 95% credible interval is marked by shaded coloured areas. The DHS data point is signified by a point on the graph with error bars displaying the standard error associated with each observation. The sectors are shown by blue triangles for public and red for the private sector.

Fig 4. Map of estimated subnational contraceptive private sector supply shares in Nigeria over time.

Fig 4

The mean estimates of private sector contraceptive method supply shares for two of the five contraceptive methods, in the six geopolitical zones of Nigeria. The colour captures the mean supply shares where light blue colours capture supply shares near 0 while the deep red colour captures supply shares approaching 100%. Five years of estimates are given at 10-yearly intervals from 1990 to 2020 and then the present year, 2025. Label ‘IUDs’ shows the supply of intra-uterine devices. Label ‘OC Pills’ shows the supply of oral contraceptive pills. Administrative boundary data were obtained from the IPUMS DHS database (https://www.idhsdata.org/idhs/), derived from The DHS Program spatial data, and are available for research use under a Creative Commons Attribution–compatible license. The figure was created by the authors using ggplot2 in R.

Rwanda.

In Rwanda, we estimate contraceptive method supply shares for the five provinces (Fig 5). The boundaries of these zones have been consistent for the duration of the observation period. Historically, the public sector has dominated the supply of all five contraceptive methods across all five provinces since 1990. The supply of implants is almost exclusively provided by the public sector, with very small proportions across all methods being privately sourced. The supply of IUDs in Kigali is at an approximately 60:40 split between the public and private sector. This is quite different to the trends we observe in the other regions where the public sector takes over 80% of the market share. The contraceptive supply market has been turbulent in Rwanda across all the regions for injectables and OC pills. In injectables, from 1990 to 2015 the market shares had remained very steady over time with little private sector involvement. However, we see that post-2015 the private sector rapidly increases it’s share of the injectables supply market and post-2020 it overtakes the public sector as the largest supplier of injectables in all regions. Similarly, in OC pills we see a rapid increase of private sector supply shares post-2015. In Kagali and the North we see that the private sector is estimated to become the largest supplier of OC pills post-2019. In the South, the OC pill market share is split at an approximate 50:50 between public and private shares. Fig 6 captures the mean trends of the private sector supply shares spatially and temporally. Across all methods, we see that Kigali provinces tends to have the strongest private sector supply share over time. From Fig 6, we see that Kigali tends to increase the private sector supply share of a given method and then the neighboring regions follow suit afterwards. Overall, private sector supply shares have historically been low in Rwanda across all regions, with the exception of OC pills (Fig 6E) and injectables (Fig 6C) in recent years.

Fig 5. Estimated subnational contraceptive supply shares in Rwanda with uncertainty.

Fig 5

The projections for the proportion of modern contraceptives supplied by each sector for four of the five contraceptive methods, in the five provinces of Nigeria. The mean estimates are shown by the continuous line while the 95% credible interval is marked by shaded coloured areas. The DHS data point is signified by a point on the graph with error bars displaying the standard error associated with each observation. The sectors are shown by blue triangles for public and red for the private sector.

Fig 6. Map of estimated subnational contraceptive supply shares in Rwanda over time.

Fig 6

The mean estimates of private sector supply shares of the five contraceptive methods across the five provinces of Nigeria. The colour captures the mean supply shares where light blue colours capture supply shares near 0 while the deep red colour captures supply shares approaching 100%. Five years of estimates are given at 10-yearly intervals from 1990 to 2020 and then the present year, 2025. The A label shows the supply of female sterilization. The B label shows the supply of implants. Label C shows the supply of injectables. Label D shows the supply of intra-uterine devices (IUDs). Label E shows the supply of oral contraceptive pills. Administrative boundary data were obtained from the IPUMS DHS database (https://www.idhsdata.org/idhs/), derived from The DHS Program spatial data, and are available for research use under a Creative Commons Attribution–compatible license. The figure was created by the authors using ggplot2 in R.

2025 estimate summary

In Table 2, we present the estimated mean method supply shares across all subnational administration regions for the year 2025. Overall, the public sector dominates in the supply of modern contraceptives at the subnational level. Implants are most commonly accessed through the public sector with a mean of approximately 83 percentage points. OC pills show an approximate 50:50 split between public and private sector market shares. In comparison to OC pills, a short-term contraceptive method, the long-acting and permanent methods, female sterilization, implants, injectables, and IUDs, have higher public sector supply shares by at least 20 percentage points in each instance. This is consistent with previous research where women were found to be more likely to access short-term methods via private facilities [8,10,11]. These findings are also consistent with the contraceptive method supply shares estimated at the national-level in 2023 [25].

Table 2. Summary of estimated contraceptive supply shares across all subnational administration regions in 2025 for each method and sector. The mean estimate for the proportion supplied and the associated standard deviation (SD) are listed.

Public Private
Mean SD Mean SD
Female Sterilization 0.773 0.095 0.207 0.095
Implants 0.829 0.160 0.119 0.157
Injectables 0.823 0.145 0.171 0.145
IUD 0.768 0.150 0.234 0.150
OC Pills 0.520 0.239 0.480 0.239

Validation results

The model described in this paper has been validated using several metrics to assess its effectiveness at estimating subnational method supply shares over time. We split our complete data into testing and training datasets, any data beyond 2015 was labeled as the test set and withheld for validation. Further details of the validation approach and the metrics used to evaluate it’s performance can be found in the Supplementary Materials. Given the complex nature of the data, the model is performing reasonably well. Table 3 gives the validation results for the Multivariate intercept P-spline model, described in the Methods section, and the modelling alternatives, described in the Supplementary Materials. First we consider the mean absolute relative error (MARE), a negatively orientated accuracy measure of each approach using the test set. The Multivariate intercept P-spline model has the lowest MARE at approximately 7 percentage points while the 0-covariance P-spline model saw the largest MARE at approximately 12 percentage points. We also consider the standardized absolute prediction error (SAPE), which is a measure of the dispersion of the generated predictive distributions for the test set. In all modelling cases, the SAPE was greater than 1. This would imply that the data is more spread out that the models are predicting. The lowest SAPE was recorded with the Fully Multivariate P-spline model at 2.81 while the largest SAPE was recorded for the shrinkage P-spline model. Our proposed model had the second smallest SAPE at 3.46. For coverage, in the 80% instance we would expect our models to capture 80% of the test set. There was some over-fitting for this metric, with the Multivariate intercept P-spline model giving a coverage of approximately 82%. This was the closest coverage to the expected 80% of all 5 models. The shrinkage P-spline model had the lowest coverage at approximately 77%. In the 95% case, we expect our models to capture 95% of the test set. In this instance, we do not see the same over-fitting issue as the 80% coverage metric. The fully multivariate P-spline model scores slightly higher than the proposed model in this instance with an approximate coverage of 95%. However, the proposed model has a marginally smaller coverage of approximately 94 percentage points. To evaluate the accuracy of our model, we considered the root mean square error (RMSE) of the public sector test set estimates. The lowest RMSE is observed in our proposed model with an approximately average error of 15 percentage points. The highest RMSE was observed in the Multivariate delta P-spline model at approximately 19 percentage points. The width of the prediction intervals (PI width) is a crucial validation metric because it directly impacts the usability of the estimates. If the PI width is too narrow, the intervals may fail to capture the true values, leading to poor coverage. On the other hand, if the PI width is too wide, the estimates become less informative and lose their practical value in other modelling scenarios. The smallest median 95% PI width was observed in the shrinkage P-spline model at approximately 44 percentage points. The largest PI width was observed for the Multivariate delta P-spline model at approximately 53 percentage points. Notably, the Multivariate intercept P-spline model provides the second smallest PI width at approximately 47 percentage points. This is 5 percentage points lower than the Multivariate delta P-spline model. Finally, in an unbiased model we would expect to see an even split of the incorrectly estimated test set observations above and below the prediction interval bounds. In all modelling instances, there are a higher proportion of incorrectly estimated observations below the 95% prediction interval. This would imply that the models tend to over-estimate the data. Given these results, we conclude that the proposed Multivariate intercept P-spline model is the performs the best overall. It has good coverage in both the 80% and 95% instances. The width of the prediction interval is not as large as other modelling alternatives, indicating that this updated model has lower uncertainty in the model estimates compared to the others. In addition, it has the lowest RMSE and MARE, and the second lowest SAPE value of all the models. Overall, the method seems to have provided reasonably accurate and well-calibrated probabilistic projections for the 2015–2022 period.

Table 3. Model validation results. The validation results for the test set across different potential modelling approaches. MARE is mean absolute relative error and is a percentage. SAPE is the standardized absolute prediction error and is measured on the logit scale. Coverage is the proportion of the test set observations that are captured within the 80% and 95% prediction intervals produced by the model. RMSE is root mean square error. We consider the median PI width and evaluate the location of the incorrectly estimated leave-one-out validation test set observations. The Multivariate intercept P-spline model is described in the Methods section, while the modelling alternatives are described in the Supplementary Materials.

Metric Multivariate intercept P-spline model Multivariate delta P-spline model 0-covariance P-spline model Shrinkage P-spline model Fully multivariate P-spline model
MARE (%) 7.42 11.25 11.86 11.16 9.10
SAPE 3.46 2.94 3.55 3.80 2.81
80% coverage (%) 81.95 82.54 77.51 76.62 82.54
95% coverage (%) 93.19 92.01 91.42 90.82 93.49
RMSE (%) 15.26 19.39 17.97 18.85 16.19
Median 95% PI width (%) 46.50 52.60 47.40 44.1 50.9
Location of incorrectly estimated observations Above the 95% PI 2.37 2.07 3.55 3.55 1.48
Below the 95% PI 4.44 5.92 4.73 5.62 5.03

Discussion

In this paper, we have developed a Bayesian method for probabilistic projections of subnational contraceptive supply shares over time with available DHS survey data. The modelling framework is based on Bayesian hierarchical models and uses penalized splines to capture the evolution of the contraceptive method supply from the public and private sectors while imposing a correlation structure to capture correlations between the most recently observed public sector supply shares. The hierarchical nature of the modelling framework allows for cross-subnational information sharing within countries to promote precise estimation, even when limited data is available. The posterior predictive distributions are estimated using past DHS data for all subnational administration regions from 1990 to 2022. The model will produce estimates within the period of available survey data as well as projections beyond the most recent data point. The resulting predictive distributions were accurate and reasonably well calibrated in an out of sample validation exercise for forecasting the most recent seven year period. The modelling framework was found to outperform other suitable alternative modelling approaches.

This modelling framework has several advantages over the aforementioned modelling alternatives, and makes another contribution to the estimation of subnational proportions. Firstly, using the Bayesian hierarchical framework accounts for the spatial nature of the data while also allowing subnational regions within a country to share information. An advantage of this is that information sharing within countries improves the precision of the resulting subnational estimates and informs model estimates where previously no data was present, all in a data-driven approach. Secondly, using a multivariate approach to hierarchal modelling accounts for the correlations that exist between method supply shares, and allows for another information exchange to occur, this time across contraceptive methods. Estimating these cross-method national- and subnational-level correlations further explains the latent trends underpinning the complexity nature of subnational method supply shares. Incorporating the observed standard errors of the DHS estimates into the data model further controls the uncertainty associated with the resulting estimates, and promotes the smooth model estimates and projections from an otherwise heterogeneous dataset. Finally, using penalised splines allows for data driven, flexible model-based estimates. For these reasons, we believe that proposed model makes a valuable contribution to the area of subnational estimation of proportions, in data sparse settings.

In addition, the approach introduces two key improvements over previous approaches of Comiskey et al. (2023) and Comiskey et al. (2024). First, it captures non-zero covariances between proxy-intercepts rather than between rates of change. Since subnational data tends to be noisier than national-level supply share data, correlations between rates of change are often difficult to estimate and uncertain. By allowing the most recently observed levels to share information across methods, this approach enhances estimate precision in data-sparse regions. Second, the model adopts a fully Bayesian process for estimating covariance matrices, replacing the earlier method of Comiskey et al. (2024) that relied on a posteriori correlation estimates. This update is not only more computationally efficient but also avoids restricting the parameter space of the resulting covariance matrix. Overall, this updated model more effectively captures the complexities of subnational data, while still offering insights into cross-method correlations and spatial relationships found in the previous approach of Comiskey et al. (2024).

In recent years, a substantial number of low- and middle-income countries have implemented a dencentralised health sector making the estimation of health indicators in data-sparse, small-areas of vital importance to researchers and policy-makers [12]. However, the lack of reliable data and regular subnational estimates of key indicators have reduced the ability of health and development authorities’ to strengthen the delivery of contraception and other reproductive health services via local systems [14]. When evaluating health programmes, policymakers must consider cost, access and quality [44]. A potential application of these subnational method supply shares is in the evaluation of access. Strengthening access to contraceptives through public-private sector collaborations and complementing ongoing public-private partnerships for the advocacy of family planning can lead to an increase in contraceptive uptake [45]. It is well-established that teenagers and sexually active unmarried women tend to use private sector suppliers of contraception [46]. However, as seen in our country case studies of subnational contraceptive supplied in Nigeria and Rwanda, many contraceptives are supplied almost solely by the public sector across many subnational regions. These model estimates provide valuable insights for policymakers into the temporal and spatial dynamics of the subnational contraceptive supply share markets, highlighting areas for potential improvement in supply dynamics and equity. Having public and private sectors both supplying contraceptives is key to achieving equity among family planning users [11], but our case studies have shown that for some contraceptives the private sector is supplying very low proportions of some contraceptives over time. Lastly, a total-market approach is essential to the success and sustainability of the family planning market. Strengthening supply chains through informed data-driven supply share estimates will contribute to ensuring contraceptive security for women and girls globally [47].

In future work, we hope to incorporate additional demographic and family planning indicator covariates into the modelling framework to further improve the precision of the model estimates. We hope to extend the framework to account for multiple data sources, accounting for the different sources of error.

Supporting information

S1 File. Supplementary Materials: Bayesian probabilistic projections of proportions with limited data [4852].

(PDF)

pone.0345413.s001.pdf (196KB, pdf)

Data Availability

All files are available from: https://github.com/hannahcomiskey/Comiskey_PlosOnepaper.

Funding Statement

Worapree Maneesoonthorn and Hannah Comiskey gratefully acknowledge support by the Australian Research Council through grant DP200101414. David Frazier gratefully acknowledges funding from the Australian Research Council under Projects DE200101070 and DP200101414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Foundation FP, United Nations. What we do. 2024. https://www.fp2030.org/about/
  • 2.FP2030. Family Planning 2020: Rights & Empowerment Principles for Family Planning. 2020. https://www.fp2030.org/resources/resources-family-planning-2020-rights-empowerment-principles-family-planning/
  • 3.DeLong R, Rosen R, Holtz J. Understanding Private Sector Domestic Resource Mobilization for Health. 2020.
  • 4.Cahill N, Sonneveldt E, Stover J, Weinberger M, Williamson J, Wei C, et al. Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool. Lancet. 2018;391(10123):870–82. doi: 10.1016/S0140-6736(17)33104-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cutherell A, Doi N, Christofield M, Sathyandran J, Fatima A, Haider H. Leveraging the private sector to expand access to contraception in the era of decreasing donor funding. 2024. https://knowledgesuccess.org/2024/06/06/leveraging-the-private-sector-to-expand-access-to-contraception-in-the-era-of-decreasing-donor-funding/#::text=The%20private%20sector%20has%20been,methods%2C%20like%20condoms%20and%20pills
  • 6.Ross J. Improved reproductive health equity between the poor and the rich: an analysis of trends in 46 low-and middle-income countries. Global Health: Science and Practice. 2015;3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chakraborty NM, Sprockett A. Use of family planning and child health services in the private sector: an equity analysis of 12 DHS surveys. Int J Equity Health. 2018;17(1):50. doi: 10.1186/s12939-018-0763-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Weinberger M, Callahan S. The private sector: key to achieving family planning 2020 goals. 2017.
  • 9.World Health Organisation. WHO launches online learning programme to increase access to contraception via pharmacies. 2024. https://www.who.int/news/item/25-09-2024-who-launches-online-learning-programme-to-increase-access-to-contraception-via-pharmacies
  • 10.Corroon M, Kebede E, Spektor G, Speizer I. Key Role of Drug Shops and Pharmacies for Family Planning in Urban Nigeria and Kenya. Glob Health Sci Pract. 2016;4(4):594–609. doi: 10.9745/GHSP-D-16-00197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bradley SEK, Shiras T, Findings K. Where Women Access Contraception in 36 Low-and Middle-Income Countries and Why It Matters. Global Health: Science and Practice. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bossert TJ, Beauvais JC. Decentralization of health systems in Ghana, Zambia, Uganda and the Philippines: a comparative analysis of decision space. Health Policy Plan. 2002;17(1):14–31. doi: 10.1093/heapol/17.1.14 [DOI] [PubMed] [Google Scholar]
  • 13.Wu Y, Li ZR, Mayala BK, Wang H, Gao PA, Paige J. Spatial modeling for subnational administrative level 2 small-area estimation. 2021. https://dhsprogram.com/pubs/pdf/SAR21/SAR21.pdf
  • 14.Li Q, Louis TA, Liu L, Wang C, Tsui AO. Subnational estimation of modern contraceptive prevalence in five sub-Saharan African countries: a Bayesian hierarchical approach. BMC Public Health. 2019;19(1):216. doi: 10.1186/s12889-019-6545-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mercer LD, Lu F, Proctor JL. Sub-national levels and trends in contraceptive prevalence, unmet need, and demand for family planning in Nigeria with survey uncertainty. BMC Public Health. 2019;19(1):1752. doi: 10.1186/s12889-019-8043-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wakefield J, Fuglstad G-A, Riebler A, Godwin J, Wilson K, Clark SJ. Estimating under-five mortality in space and time in a developing world context. Stat Methods Med Res. 2019;28(9):2614–34. doi: 10.1177/0962280218767988 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ghosh M, Rao JNK. Small Area Estimation: An Appraisal. Statistical Science. 1994;9:55–93. doi: 10.1214/ss/1177010647 [DOI] [Google Scholar]
  • 18.Fay RE, Herriot RA. Estimates of Income for Small Places: An Application of James-Stein Procedures to Census. 1979.
  • 19.Besag J, York J, Mollii A. Bayesian image restoration, with two applications in spatial statistics. 1991.
  • 20.Chen C, Wakefield J, Lumely T. The use of sampling weights in Bayesian hierarchical models for small area estimation. Spat Spatiotemporal Epidemiol. 2014;11:33–43. doi: 10.1016/j.sste.2014.07.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Alexander M, Zagheni E, Barbieri M. A Flexible Bayesian Model for Estimating Subnational Mortality. Demography. 2017;54(6):2025–41. doi: 10.1007/s13524-017-0618-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wah W, Ahern S, Earnest A. A systematic review of Bayesian spatial–temporal models on cancer incidence and mortality. 2020. [DOI] [PubMed]
  • 23.Tessema ZT, Tesema GA, Ahern S, Earnest A. A Systematic Review of Areal Units and Adjacency Used in Bayesian Spatial and Spatio-Temporal Conditional Autoregressive Models in Health Research. 2023. [DOI] [PMC free article] [PubMed]
  • 24.Peterson EN, Nethery RC, Padellini T, Chen JT, Coull BA, Piel FB, et al. A Bayesian hierarchical small area population model accounting for data source specific methodologies from american community survey, population estimates program, and decennial census data. Ann Appl Stat. 2024;18(2):1565–95. doi: 10.1214/23-aoas1849 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Comiskey H, Alkema L, Cahill N. Estimating the proportion of modern contraceptives supplied by the public and private sectors using a Bayesian hierarchical penalized spline model. Journal of the Royal Statistical Society Series A: Statistics in Society. 2024;188(2):474–90. doi: 10.1093/jrsssa/qnae051 [DOI] [Google Scholar]
  • 26.Comiskey H, Cahill N. mcmsupply: An R Package for Estimating Contraceptive Method Market Supply Shares. 2023. https://arxiv.org/abs/2308.09434
  • 27.The DHS Program. Antenatal Care. n.d. https://dhsprogram.com/data/Guide-to-DHS-Statistics/Antenatal_Care.htm
  • 28.Dickson KS, Darteh EKM, Kumi-Kyereme A, Ahinkorah BO. Determinants of choice of skilled antenatal care service providers in Ghana: analysis of demographic and health survey. Matern Health Neonatol Perinatol. 2018;4:14. doi: 10.1186/s40748-018-0082-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.The DHS Program. Vaccination. n.d. https://dhsprogram.com/data/Guide-to-DHS-Statistics/Vaccination.htm
  • 30.Agopian A, Sedrakyan T, Muradyan D, Sahakyan G. The prolonged impact of the COVID-19 pandemic on routine childhood vaccinations in Armenia: a time-series analysis. BMC Public Health. 2025;25(1):3948. doi: 10.1186/s12889-025-24912-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hubacher D, Trussell J. A definition of modern contraceptive methods. 2015. [DOI] [PubMed]
  • 32.Data for Impact (D4I), United States Agency for International Development (USAID). Source of supply (by method). 2024. https://www.data4impactproject.org/prh/family-planning/fp/source-of-supply-by-method/
  • 33.Boyle EH, King M, Sobek M. IPUMS-Demographic and Health Surveys: Version 11. 2024. 10.18128/D080.V11 [DOI]
  • 34.Smithson M, Verkuilen J. A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables. Psychol Methods. 2006;11(1):54–71. doi: 10.1037/1082-989X.11.1.54 [DOI] [PubMed] [Google Scholar]
  • 35.Binder DA. On the Variances of Asymptotically Normal Estimators from Complex Surveys. International Statistical Review / Revue Internationale de Statistique. 1983;51(3):279. doi: 10.2307/1402588 [DOI] [Google Scholar]
  • 36.Lavrakas PJ. Taylor Series Linearization (TSL). In: Lavrakas PJ. Encyclopedia of Survey Research Methods. Thousand Oaks, CA: SAGE Publications. 2013. [Google Scholar]
  • 37.Susmann H, Alexander M, Alkema L. Temporal Models for Demographic and Global Health Outcomes in Multiple Populations: Introducing a New Framework to Review and Standardise Documentation of Model Assumptions and Facilitate Model Comparison. Int Stat Rev. 2022;90(3):437–67. doi: 10.1111/insr.12491 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Track20. Monitoring Progress in Family Planning Estimated Modern Use (EMU): A New Service Statistics-Based Family Planning Indicator. 2020. http://fpet.track20.org/fpet/
  • 39.Zhang Z. A Note on Wishart and Inverse Wishart Priors for Covariance Matrix. JBDS. 2021;1(2). doi: 10.35566/jbds/v1n2/p2 [DOI] [Google Scholar]
  • 40.Oehlert GW. A Note on the Delta Method. The American Statistician. 1992;46(1):27–9. doi: 10.1080/00031305.1992.10475842 [DOI] [Google Scholar]
  • 41.Hornik K, Leisch F, Zeileis A, Plummer M. JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling. In: International Workshop on Distributed Statistical Computing, 2003. 10.1002/ana.1067 [DOI]
  • 42.Plummer M, Stukalov A, Denwood M. Package ‘rjags’. 2022. https://mcmc-jags.sourceforge.io
  • 43.Vehtari A, Gelman A, Simpson D, Carpenter B, Bürkner P-C. Rank-Normalization, Folding, and Localization: An Improved Rˆ for Assessing Convergence of MCMC (with Discussion). Bayesian Anal. 2021;16(2). doi: 10.1214/20-ba1221 [DOI] [Google Scholar]
  • 44.Shah NM, Wang W, Bishai DM. Comparing private sector family planning services to government and NGO services in Ethiopia and Pakistan: how do social franchises compare across quality, equity and cost?. Health Policy and Planning. 2011;26. doi: 10.1093/heapol/czr027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.White JN, Corker J. Applying a total market lens: Increased IUD service delivery through complementary public-and private-sector interventions in 4 countries. 2016. [DOI] [PMC free article] [PubMed]
  • 46.Elnakib S, Elsallab M, Wanis MA, Elshiwy S, Krishnapalan NP, Naja NA. Understanding the impacts of child marriage on the health and well-being of adolescent girls and young women residing in urban areas in Egypt. Reprod Health. 2022;19(1):8. doi: 10.1186/s12978-021-01315-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Moazzam A, Farron M. Ensuring contraceptive security through effective supply chains. 2017. https://www.who.int/publications/i/item/WHO-RHR-17.09
  • 48.ICF I. Demographic and Health Survey Sampling and Household Listing Manual. 2012.
  • 49.Demographic and Health Surveys. Final DHS Reports, Appendix B: Estimates of Sampling Errors. n.d.
  • 50.Park I, Lee H. Variance estimation using Taylor linearization in complex sample surveys. Survey Research. 2004;5(1):25–44. [Google Scholar]
  • 51.Cadonna A, Frühwirth-Schnatter S, Knaus P. Triple the Gamma—A Unifying Shrinkage Prior for Variance and Variable Selection in Sparse State Space and TVP Models. Econometrics. 2020;8(2):20. doi: 10.3390/econometrics8020020 [DOI] [Google Scholar]
  • 52.Knaus P, Bitto-Nemling A, Cadonna A, Frühwirth-Schnatter S. Shrinkage in the Time-Varying Parameter Model Framework Using the R Package shrinkTVP. J Stat Soft. 2021;100(13). doi: 10.18637/jss.v100.i13 [DOI] [Google Scholar]

Decision Letter 0

Juan Pablo Gutierrez

7 Nov 2025

Dear Dr. Comiskey,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 22 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols....

We look forward to receiving your revised manuscript.

Kind regards,

Juan Pablo Gutierrez

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“Worapree Maneesoonthorn and Hannah Comiskey gratefully acknowledge support by the Australian Research Council through grant DP200101414. David Frazier gratefully acknowledges funding from the Australian Research Council under Projects DE200101070 and DP200101414.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Please note that your Data Availability Statement is currently missing the DOI/accession number of each dataset. If your manuscript is accepted for publication, you will be asked to provide these details on a very short timeline. We therefore suggest that you provide this information now, though we will not hold up the peer review process if you are unable.

4. Please ensure that you refer to Figure 5 in your text as, if accepted, production will need this reference to link the reader to the figure.

5. We note that Figures 4 and 6 in your submission contain mapimages which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure(s) [#] to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

6. Please upload a copy of Supporting Information figure/table which you refer to in your text on page 10.

7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments:

Please review the comments from the reviewers and address them accordingly. Provide the additional details requested to assess the methodology.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The paper proposes a novel approach to produce Bayesian probabilistic projections of contraceptive method supply shares at the subnational level, especially in data-sparse settings. The authors state that their modelling framework builds on Bayesian hierarchical models and uses penalized splines, leveraging the spatial nature of data and incorporating a correlation structure between recent supply share observations at national and subnational levels. They explicitly mention improvements over previous approaches, including those by Comiskey et al., 2024, by capturing non-zero covariances between proxy-intercepts and adopting a fully Bayesian process for estimating covariance matrices. This demonstrates original research by extending existing methodologies to address a specific, complex problem in a new way.

Here are the few points to address which can strengthen the paper:

In Introduction section:

• Novelty vs. prior work: Make the distinction from Comiskey et al. (2024) (or any prior national-level model) explicit in the Introduction (authors do make distinctions from Comiskey et al. (2024) and other prior approaches, but primarily in the "Methods" and "Discussion" sections, rather than explicitly in the Introduction).

• Scope and generalisability: Clarify to what extent the framework can be ported to other small-area proportion estimation problems (e.g., immunisation source, ANC service mix). A brief paragraph on external applicability will broaden impact.

In Data section:

• Briefly justify the choice of FP2030 countries and administrative unit definitions. It would be good to Include a short table summarising: country, admin level used, number of regions, survey years.

• It would be good to state why penalised splines were preferred (e.g., smoother long-term trends, fewer parameters) and whether a RW1/RW2 (Random Walks) alternative was tested.

• It would be interesting to report the posterior summaries of the off-diagonal covariance terms (e.g., specific numerical values for the correlations or their magnitudes) to demonstrate their substantive nature.

• The paper will strengthen with explicitly showing sensitivity analysis (e.g., by testing LKJ priors or a separation strategy) to demonstrate robustness.

• While the paper clearly explains its use of a normal-on-logit likelihood, it does not explicitly discuss the implications of this choice when proportions are at or near 0 or 1, where the logit transformation can lead to infinite values and large variances.

• The paper does not provide any justification for the sufficiency of the number of draws (4000 total) based on Effective Sample Size (ESS) metrics, also it does not report any ESS statistics for key parameters. Reporting ESS would indeed be valuable for demonstrating the robustness and efficiency of the sampling process.

Lastly, the paper uses a mix of British and American language. Please choose one and make it coherent throughout the paper. For example in some places the author have used localized and in some localised, similarly modelling and modelling, decentralized and desentralised.

Reviewer #2: This manuscript proposes a method for projecting the proportions of each

contraceptive method at the subnational level. This is an important

problem that has already been addressed at the national level by

Comiskey et al (2024). The manuscript adapts the method to subnational

regions. It also extends the method by accounting for cross-method

correlations, which was not previously done.

It also simplifies the previous method by replacing the previous three-level

model by a two-level model. Academic publication tends to reward

ever-increasing complication, and this goes in the opposite direction.

It has several advantages, including greater simplicity of implementation, ease

of interpretation, and ease of communication to users.

So this simplification is actually an advance, and is a strong point of

the manuscript.

My main concern has to do with the spatial modeling.

The claim is made that spatial correlation is included in the modelling,

but I couldn't find how that is done described in the manuscript.

I would have expected to find it in the process model or data model section.

This makes it hard to evaluate the modelling approach overall.

**********

what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #1: Yes: Adnan KhanAdnan KhanAdnan KhanAdnan Khan

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Apr 24;21(4):e0345413. doi: 10.1371/journal.pone.0345413.r002

Author response to Decision Letter 1


1 Feb 2026

We would like to thank the editor and the reviewers for their helpful comments and feedback. These constructive comments have improved the paper overall. We have revised the manuscript in response to the comments. The main changes to the paper are;

1. Addition of a cross-country level average to have a complete hierarchical set up for the intercepts. This update did not affect parameter estimates or validation, however for completeness it is import to include it.

2. Updated the introduction section to highlight the potential of the modelling approach to other small-area estimation problems.

3. Updated explanations of the modelling approach, including a more detailed explanation in the context of spatial analysis.

4. Added an explanation of the data imputation approach to the Supplementary Materials.

In what follows, points and comments from the reviewers are highlighted in red and our responses are in black. The line numbers for the updated sections are listed in the response. In the updated PDF document, the below cited passages of text are highlighted in blue.

Journal Requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

We have updated the file names to meet the PLOS ONE's style requirements.

2. Thank you for stating the following financial disclosure:

“Worapree Maneesoonthorn and Hannah Comiskey gratefully acknowledge support by the Australian Research Council through grant DP200101414. David Frazier gratefully acknowledges funding from the Australian Research Council under Projects DE200101070 and DP200101414.”

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

We have updated the Supplementary materials to include this information (lines 623-627):

“Worapree Maneesoonthorn and Hannah Comiskey gratefully acknowledge support by the Australian Research Council through grant DP200101414. David Frazier gratefully acknowledges funding from the Australian Research Council under Projects DE200101070 and DP200101414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

3. Please note that your Data Availability Statement is currently missing the DOI/accession number of each dataset. If your manuscript is accepted for publication, you will be asked to provide these details on a very short timeline. We therefore suggest that you provide this information now, though we will not hold up the peer review process if you are unable.

We have updated the Supplementary materials to include this information (lines 480-483):

“The complete set of subnational supply share estimates for every country and subnational administration region can be reproduced using the code and data found on the github, https://github.com/hannahcomiskey/Comiskey_PlosOnepaper.”

4. Please ensure that you refer to Figure 5 in your text as, if accepted, production will need this reference to link the reader to the figure.

We have addressed this typo. Line 308 now reads,

“In Rwanda, we estimate contraceptive method supply shares for the five provinces (Fig. 5).”

5. We note that Figures 4 and 6 in your submission contain mapimages which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

These maps are generated using the R package ggplot2 and freely available shape files from IPUMS.

6. Please upload a copy of Supporting Information figure/table which you refer to in your text on page 10.

We have addressed this typo, it now reads:

“Further details of the validation approach and the metrics used to evaluate it's performance can be found in the Supplementary Materials.”

Reviewer #1:

The paper proposes a novel approach to produce Bayesian probabilistic projections of contraceptive method supply shares at the subnational level, especially in data-sparse settings. The authors state that their modelling framework builds on Bayesian hierarchical models and uses penalized splines, leveraging the spatial nature of data and incorporating a correlation structure between recent supply share observations at national and subnational levels. They explicitly mention improvements over previous approaches, including those by Comiskey et al., 2024, by capturing non-zero covariances between proxy-intercepts and adopting a fully Bayesian process for estimating covariance matrices. This demonstrates original research by extending existing methodologies to address a specific, complex problem in a new way.

In Introduction section:

• Novelty vs. prior work: Make the distinction from Comiskey et al. (2024) (or any prior national-level model) explicit in the Introduction (authors do make distinctions from Comiskey et al. (2024) and other prior approaches, but primarily in the "Methods" and "Discussion" sections, rather than explicitly in the Introduction).

An extensive explanation for the distinction from Comiskey et al. 2024 is now given between lines 53 and 74:

“Previous works modelled the distribution of contraceptive method supply shares at the national level using a Bayesian hierarchical penalized spline model, and then explored the application of this modelling framework to subnational data (Comiskey et al. 2024, Comiskey et al. 2023). While performing relatively well across a range of validation measures, this paper revisits the modelling framework of Comiskey et al. (2024) with the aim of improving its suitability for estimating and projecting proportions, while addressing the complex structure of subnational DHS administrative data. In this article, we describe a Bayesian hierarchical penalized spline model that produces annual, subnational, and method-specific estimates of the proportion of modern contraceptives coming from the public sector. In the context of SAE, Bayesian hierarchical models allow for the pooling of information across larger populations to inform smaller sub-population estimates, where data is sparser. As a result, these models provide a powerful framework for estimating subnational method supply shares. The Comiskey et al. (2024) approach also estimates and incorporates cross-method correlations to inform the rates of change in spline coefficients. However, due to the heterogeneity of subnational data, capturing cross-method correlations within the rates of change between spline coefficients becomes difficult. Instead, we present an approach that captures the cross-method correlations for the most recently observed survey levels of public sector supply shares. Finally, Comiskey et al. (2024) estimate a multivariate compositional outcome across three-way breakdown of the contraceptive supply market. Due to small sample sizes at the subnational level, we instead focus on a simplified public–private breakdown of the outcome.”

• Scope and generalisability: Clarify to what extent the framework can be ported to other small-area proportion estimation problems (e.g., immunisation source, ANC service mix). A brief paragraph on external applicability will broaden impact.

We have added in a paragraph (lines 87-95) discussing the generalisability of this method:

“While our focus is the specific supply-share monitoring scenario, we note that this more parsimonious modeling approach is highly generalisable and can be applied to a wide range of datasets beyond the current context. By structuring the model to capture both hierarchical dependencies and flexible distributional assumptions, it can accommodate different levels of aggregation, varying sample sizes, and diverse outcome types; e.g., the proportion of women who received antenatal care from a skilled provider or proportion of children vaccinated between 12-23 months”

In Data section:

• Briefly justify the choice of FP2030 countries and administrative unit definitions. It would be good to Include a short table summarising: country, admin level used, number of regions, survey years.

We have updated the data source section (lines 127-131) to include the following justification:

“The countries included in this study are selected from those participating in the FP2030 initiative with IPUMS-DHS data available after 2012 and were also previously considered in Comiskey et al. 2024. There are 23 countries containing 160 subnational regions, included in this study. The administration level used was the integrated geographic units calculated by IPUMS. Using the integrated geographic units ensured that the data had consistent boundaries across all years.”

• It would be good to state why penalised splines were preferred (e.g., smoother long-term trends, fewer parameters) and whether a RW1/RW2 (Random Walks) alternative was tested.

We are currently employing an RW1 approach to the estimation of the spline coefficients. Higher order RW can be recovered if supported by the data. An explanation for the use of splines is added on lines 173-176:

“The use of a random walk model of order 1 to estimate the coefficients of the penalised splines allows us to flexibly model non-linear trends, while the penalty term controls the degree of smoothness and prevents overfitting.”

• It would be interesting to report the posterior summaries of the off-diagonal covariance terms (e.g., specific numerical values for the correlations or their magnitudes) to demonstrate their substantive nature.

Figure 2 (line 290) shows a heat map of the estimated mean correlations with associated 95% credible intervals captured by the Wishart prior for the intercept term of the proposed model. Estimated (A) national- and (B) subnational-level cross-method correlations informing \alpha_{p,m}, the proxy-intercept.

• The paper will strengthen with explicitly showing sensitivity analysis (e.g., by testing LKJ priors or a separation strategy) to demonstrate robustness.

We carried out a sensitivity analysis using a more conservative Wishart prior. We did not use an LKJ prior as it is not available in JAGS. Furthermore, we found that a separation strategy led to model estimates that did not converge. Using the more conservative priors, we found the correlations remained unchanged. We updated the Supplementary Materials to include this detail (lines 613-621):

‘To assess the robustness of our estimated correlations, we conducted a prior sensitivity analysis by increasing the degrees of freedom in the Inverse-Wishart prior used for the variance–covariance matrices of the spline coefficients. Specifically, we considered a more informative prior of the form

\mathrm{\Sigma}_\theta ∼ IW (I_M , M + 5), \mathrm{\Sigma}_\alpha ∼ IW (I_M, M + 5),

where the additional degrees of freedom impose stronger shrinkage toward the identity matrix. This in turn induces greater shrinkage of the off-diagonal elements, pulling the implied correlations closer to zero. We found no significant difference in the estimated correlations from this more conservative prior.’

Below is a side-by-side comparison of the correlations estimated with M+1 degrees of freedom and M+5 degrees of freedom:

Figure 1. Estimated (A) national- and (B) subnational-level cross-method correlations informing \alpha_{p,m}, the proxy-intercept estimated from an Inverse Wishart prior with M+1 degrees of freedom. The estimated mean correlations captured by the Wishart prior for the intercept term of the proposed model. The intercept is informed by the most recently observed public supply shares of each method across all (A) countries and (B) subnational administration regions. Each of the five methods is listed along the x- and y-axes, with the estimated mean correlation is given in each square. The strength of the correlation is emphasised by the depth of the shade. Lighter infer correlations closer to 0, while darker colours infer stronger correlations.

Figure 2. Estimated (A) national- and (B) subnational-level cross-method correlations informing \alpha_{p,m}, the proxy-intercept estimated from an Inverse Wishart prior with M+5 degrees of freedom. The estimated mean correlations captured by the Wishart prior for the intercept term of the proposed model. The intercept is informed by the most recently observed public supply shares of each method across all (A) countries and (B) subnational administration regions. Each of the five methods is listed along the x- and y-axes, with the estimated mean correlation is given in each square. The strength of the correlation is emphasised by the depth of the shade. Lighter infer correlations closer to 0, while darker colours infer stronger correlations.

• While the paper clearly explains its use of a normal-on-logit likelihood, it does not explicitly discuss the implications of this choice when proportions are at or near 0 or 1, where the logit transformation can lead to infinite values and large variances.

A paragraph has been added to the Data sources section (lines 133-142) have been added that explain how we deal with exact 0s and 1s:

“To avoid issues with exact zeros or ones, on the logit scale, the data was condensed using the `lemon-squeezer' method. This simple transformation slightly shrinks all data points away from 0 and 1 while maintaining their relative ordering and approximate scale. To address issues with small sample size, we filtered the database to only include observations where at least one sector (public or private) has a sample size of at least 10 women. This removes sets of observations with large uncertainty due to small sample sizes. Sampling errors were calculated while accounting for the sampling design using a Taylor series linearisation method to approximate the standard error of the calculated proportions. A complete description of this imputation process is described in the Supplementary Materials”

• The paper does not provide any justification for the sufficiency of the number of draws (4000 total) based on Effective Sample Size (ESS) metrics, also it does not report any ESS statistics for key parameters. Reporting ESS would indeed be valuable for demonstrating the robustness and efficiency of the sampling process.

On line 240-243, we have clarified the description of our convergence assessment. We use of R-hat values to evaluate convergence and ESS to evaluate autocorrelation. For parameters with lower ESS, we considered their individual autocorrelation plots and deemed them to be sufficient. The publicly available R vignette to reproduce these results includes the functions to look at these diagnostics so that users can produce the plots themselves.

“To assess convergence, we considered the R-hat and effective sample size (ESS) values of the model parameters using the plot function of rjags, as well as the trace plots and autocorrelation function plots of individual parameters”

• Lastly, the paper uses a mix of British and American language. Please choose one and make it coherent throughout the paper. For example in some places the author have used localized and in some localised, similarly modelling and modelling, decentralized and decentralised.

The spelling has been adjusted for consistency.

Reviewer #2:

This manuscript proposes a method for projecting the proportions of each contraceptive method at the subnational level. This is an important problem that has already been addressed at the national level by Comiskey et al (2024). The manuscript adapts the method to subnational regions. It also extends the method by accounting for cross-method correlations, which was not previously done. It also simplifies the previous method by rep

Attachment

Submitted filename: Reviewer_comments_response.pdf

pone.0345413.s002.pdf (444.4KB, pdf)

Decision Letter 1

Juan Pablo Gutierrez

6 Mar 2026

Bayesian probabilistic projections of proportions with limited data: An application to subnational contraceptive method supply shares.

PONE-D-25-25522R1

Dear Dr. Comiskey,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support....

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Juan Pablo Gutierrez

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

**********

Reviewer #2: (No Response)

**********

what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #2: No

**********

Acceptance letter

Juan Pablo Gutierrez

PONE-D-25-25522R1

PLOS One

Dear Dr. Comiskey,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Juan Pablo Gutierrez

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Supplementary Materials: Bayesian probabilistic projections of proportions with limited data [4852].

    (PDF)

    pone.0345413.s001.pdf (196KB, pdf)
    Attachment

    Submitted filename: Reviewer_comments_response.pdf

    pone.0345413.s002.pdf (444.4KB, pdf)

    Data Availability Statement

    All files are available from: https://github.com/hannahcomiskey/Comiskey_PlosOnepaper.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES